Delivery Order SPE2DB22D1017-SPE2DB24FF5RR
Award Date 4/10/24
Potential Completion Date 4/11/24
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL at a firm fixed price of $1,036.86. The contract has a period of performance through March 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Insulin Lispro 100 unit/mL Pen 3mL. The contract has a firm fixed price of $1,529.48 and a completion date of May 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.05 firm fixed-price contract is for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen is the prime contractor, and there are no noted subcontractors. The contract is not...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a diabetes medication. The contract has a firm fixed price of $1,190.81 and an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program and is open competition. Amerisourcebergen Drug Corp is the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL, a diabetes medication. The contract has a ceiling value of $1,517.52 and a completion date of June 16, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL. The contract has a ceiling value of $1,198.85 and a period of performance through April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,057.47 delivery order is for the supply of insulin lispro 100 unit/mL pens, a critical medication for diabetes management. The contract has a firm fixed price and runs until September 14, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Lispro 100 Unit/mL pen 3mL vials, with a ceiling value of $1,292.88. This non-set-aside contract employs firm fixed price terms with an ultimate completion date of September 29, 2025. The order represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
- The Defense Logistics Agency awarded a $875 firm fixed price delivery order to Amerisourcebergen Drug Corporation for insulin lispro pen injectors. As the prime contractor, Amerisourcebergen will supply 100 units/mL pens containing 3mL of insulin lispro each to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 26-27, 2023. The delivery order was issued under an existing DLA-wide contract vehicle, though further...